|
ciprofol Clinical Trials
2 actively recruiting trials
Also known as: Cipepofol, HSK3486, Sishuning
Pipeline
Phase 4: 1
Top Sponsors
- Tongji Hospital1
- Shanghai Geriatric Medical Center1
Indications
- Osteoarthritis, Knee and Hip1
- Hip Fractures (ICD-10 72.01-72.2)1
- Femoral Neck Fractures1
- Heart Disease1
- Thoracoscopic Surgery1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.